Skip to main content
    I

    I-Mab (IMAB)

    BIOTECHNOLOGY

    $4.63
    -0.01 (-0.22%)

    Last updated: Oct 29, 2025 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(8/16)
    Avg Surprise
    +3.91%
    Streak
    3 Q
    Last 12 of 30 reported quarters
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Sep 25
    Reported Nov 13
    		$0.00N/A-+100.00%Beat--+100.0%
    Jun 25
    Reported Aug 20
    		$-0.07$-0.10-+30.00%Beat--+0.0%
    Mar 25
    Reported May 15
    		$-0.04$-0.06-+33.33%Beat--+84.3%
    Dec 24
    Reported Mar 12
    		$-0.06$-0.05--20.00%Miss1--487.1%
    Sep 24
    Reported Nov 14
    		$-0.25$-0.16--56.25%Miss---1.0%
    Jun 24
    Reported Aug 28
    		$-0.07N/A-+86.27%Beat--+74.9%
    Mar 24
    Reported Apr 30
    		$-0.26N/A-N/ABeat--+54.4%
    Dec 23
    Reported Mar 29
    		$0.02N/A-+116.17%Beat--+101.5%
    Sep 23
    Reported Sep 30
    		$-0.25N/A-N/ABeat--+40.1%
    Jun 23
    Reported Aug 17
    		$-0.28$-0.26--7.23%Miss--+48.0%
    Mar 23
    Reported May 1
    		$-0.56N/A-N/ABeat---23.3%
    Dec 22
    Reported Mar 30
    		$-1.01$-0.49--106.12%Miss---131.5%

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$5.01
    SMA 20$5.00
    SMA 50$4.48
    SMA 200N/A
    EMA 10$4.81
    EMA 20$4.80
    EMA 50$4.38
    EMA 200$2.79

    MACD

    Line: 0.11Signal: 0.24Hist: -0.14

    ADX

    ADX: 16.8+DI: 24.0-DI: 23.0

    Aroon & PSAR

    Aroon Up64.0
    Aroon Down12.0
    PSAR$5.94

    Bollinger Bands

    Upper Band$6.42
    Lower Band$3.57
    %B Position5692%(Upper)
    Band Width0.37

    RSI (14-Day)

    Neutral
    48.8

    Momentum Oscillators

    Stoch %K19.8
    Stoch %D15.9
    Williams %R-81.2
    ROC (10d)-24.5%
    Momentum-1.50
    CCI (20d)-41.8
    MFI (14d)53.9

    Volatility Measures

    ATR (14d)$0.57(12.2%)
    StdDev (20d)0.71
    Hist Vol133.8%(High)

    Volume Flow

    VWAP$4.63
    OBV70.7M
    AD Line-11.7M
    CMF (20d)0.118

    Volume Metrics

    Avg Vol (20d)2.2M
    Vol Ratio0.7x
    VWMA (20d)$5.14

    Pivot Points

    R3$5.32
    R2$5.10
    R1$4.87
    Pivot Point$4.65
    S1$4.42
    S2$4.20
    S3$3.97

    Advanced Oscillators

    TSI5.76
    Ultimate Osc48.6
    KST262.19

    Financial Data

    QuarterJun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022
    Total Revenue$0$0$0$0$0$0$1.14M$1.17M$9.83M$9.83M$574.53M$-136,710,500
    Cost of Revenue$0$0$0$0$0$0$0$0$0$0$27.24M$0
    Gross Profit$0$0$0$0$0$0$-19,163,691$1.17M$9.83M$9.83M$-136,710,500$-136,710,500
    Operating Expenses$992,047$723,232$1.83M$1.77M$17.14M$90.62M$176.00M$181.04M$345.71M$345.71M$482.20M$437.80M
    R&D$459,348$106,713$825,868$637,732$15.06M$38.95M$101.07M$5.09M$223.22M$223.22M$79.79M$226.14M
    SG&A$532,699$616,519$1.01M$1.13M$11.94M$51.67M$-285,096,177$5.86M$122.50M$122.50M$402.41M$211.65M
    Operating Income$-992,047$-723,232$-1,831,292$-1,768,834$-17,141,114$-90,620,885$-174,868,000$335.48M$-335,886,000$-335,886,000$1.03B$1.03B
    Interest Income$251,010$257,100$300,901$349,006$264,348$709,000$311,313$10.37M$-18,524,500$15.15M$10.17M$10.17M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-767,532$-432,621$-1,485,194$-2,920,172$-6,809,799$-69,981,086$-236,860,000$-456,037,999$-386,398,000$-386,398,000$803.57M$803.57M
    Income Tax Expense$0$0$0$0$-5,872,675$0$0$0$0$0$348,500$348,500
    Net Income$-767,532$-432,621$-1,241,131$-2,920,172$3.46M$20.84M$-346,449,000$-346,449,000$-386,398,000$-386,398,000$-730,230,000$-730,230,000
    EBITDA$-992,047$-723,232$-1,656,942$-915,214$-14,184,976$-84,633,632$-276,136,250$-275,788,500$323.84M$-50,512,000$-568,170,000$-568,404,500
    EBIT$-992,047$-723,232$-1,656,942$-1,768,834$-17,141,114$-90,620,885$-282,123,500$-10,634,000$-12,050,000$-335,886,000$-574,505,000$-574,505,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about IMAB

    News

    No news available

    Company news will appear here when available

    IMAB Competitors

    CompanyTicker
    Tectonic Therapeutic, Inc.TECX
    Avalo Therapeutics IncAVTX
    Oculis Holding AG Ordinary sharesOCS
    Simulations Plus IncSLP
    TruBridge Inc.TBRG
    Embecta CorpEMBC
    KamadaKMDA
    Wellgistics Health, Inc. Common StockWGRX

    Sector: Healthcare

    IMAB Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    35.3%

    IMAB Earnings Call

    The latest IMAB earnings call transcript on file is labeled 2024Q2.

    Read the 2024Q2 transcript

    Frequently Asked Questions About IMAB

    Does IMAB pay dividends?

    I-Mab (IMAB) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In